Company Filing History:
Years Active: 1990-1997
Title: The Innovative Contributions of Alexander D. Cross
Introduction
Alexander D. Cross is a prominent inventor based in Atherton, California. He has made significant contributions to the field of photodynamic therapy through his innovative work on porphycene compounds. With a total of 9 patents to his name, Cross continues to push the boundaries of scientific research and application.
Latest Patents
Among his latest patents, Cross has developed novel 9-substituted porphycene compounds that are particularly useful in photodynamic therapy. These compounds have the formula ##STR1##, wherein each R is --(CH.sub.2).sub.n --X, with n ranging from 1 to 10. Here, X is OR.sup.1, and R.sup.1 can be alkyl, aralkyl, or aryl. These innovative compounds serve as effective photosensitizers in photodynamic therapy, showcasing Cross's commitment to advancing medical technology.
Career Highlights
Cross is currently associated with Cytopharm, Inc., where he applies his expertise in developing cutting-edge therapeutic solutions. His work has not only contributed to the scientific community but has also paved the way for new treatment options in medicine.
Collaborations
Throughout his career, Cross has collaborated with notable colleagues such as Emanuel Vogel and Clemens Richert. These partnerships have further enhanced his research and development efforts, leading to impactful innovations in his field.
Conclusion
Alexander D. Cross exemplifies the spirit of innovation in the realm of photodynamic therapy. His contributions through his patents and collaborations highlight his dedication to improving medical treatments. His work continues to inspire future advancements in the field.